| Literature DB >> 31970001 |
Rolando Crippa1, Riccardo Aiuto2, Mario Dioguardi3, María Peñarrocha-Diago2, Miguel Peñarrocha-Diago2, Francesca Angiero4.
Abstract
Placement of postextraction dental implants has become a common practice. Here, we reviewed current literature, along with clinical procedures, outcomes, and incidence of complications, associated with immediate implants in infected postextraction sites. The YSGG (yttrium, scandium, gallium, and garnet) laser can significantly reduce the bacterial concentration after extracting a compromised tooth. We treated a 40-year-old woman with a compromised tooth in the esthetic zone, presenting clinical and radiological signs of infection, particularly a periapical periodontitis. The tooth was extracted after administering local anesthesia using Optocain® (mepivacaine and adrenalin 1 : 100,000), following which the site was treated with an ErCr : YSGG (erbium, chromium-doped yttrium, scandium, gallium, and garnet) 2780 nm laser device (Biolase iPlus®). The implant (Straumann® fixture) was inserted with minimum 35 N torque, 1 mm below the most apical bone peak. Bio-Oss® and resorbable membrane were applied to improve bone healing. The use of ErCr : YSGG laser has ensured success of implant therapy performed on an infected site. There were no complications such as peri-implantitis or loss of peri-implant bone. The implant achieved good primary stability, immediate placement into an infected site did not increase complications, and the 5-year follow-up confirmed the treatment success.Entities:
Year: 2020 PMID: 31970001 PMCID: PMC6973183 DOI: 10.1155/2020/2328398
Source DB: PubMed Journal: Case Rep Dent
Figure 1Preoperative X-ray.
Figure 2Preoperative clinical condition.
Figure 3Phases of surgery.
Figure 4Tissue regeneration.
Figure 5Postoperative X-ray.
Figure 6Clinical conditions after 2 years.
Figure 71-year follow-up.
Figure 85-year follow-up.
Articles about laser treatment and immediate implant therapy.
| Author | Study design | Infected sites | Laser | Implants (no.) | Follow-up | Survival rate |
|---|---|---|---|---|---|---|
| Kusek | Case series | Yes | ErCr : YSGG | 10 | 1 year | 10/10 |
| Montoya-Salazar et al. | Prospective | Yes | ErCr : YSGG | 18 | 3 years | 17/18 |
| Crippa et al. | Case series | Yes | ErCr : YSGG | 94 | 6 months/4 years | 89/94 |
| Choi et al. | Case series | No | Nd : YAG | 6 | 9 months | 6/6 |